Type 1 vs Type 2 Diabetes: Understanding the Difference

Two Conditions, One Shared Result

Type 1 and Type 2 diabetes share a name and a core feature, both result in glucose building up in the blood rather than being properly used by the body’s cells. Beyond that shared outcome, the two conditions differ substantially in their cause, how quickly they develop, and how they’re typically treated. Understanding these differences matters not just for managing your health, but for understanding what kind of monitoring and treatment supplies your insurance is likely to cover and why.

What Makes Type 1 Diabetes Different

Type 1 diabetes is an autoimmune condition. The immune system mistakenly attacks and destroys the insulin-producing cells in the pancreas, so over time the body loses its ability to produce insulin at all. Because insulin is essential for moving glucose out of the bloodstream and into cells for energy, people with Type 1 diabetes require insulin therapy for life, whether through injections or an insulin pump.

Type 1 diabetes was once commonly called juvenile diabetes, since it’s frequently diagnosed in children and young adults, but this label is outdated. It can develop at any age, and a meaningful share of Type 1 diagnoses now occur in adulthood. Symptoms often appear relatively quickly, sometimes over just a few weeks, and can include excessive thirst, frequent urination, unexplained weight loss, and fatigue.

Because Type 1 diabetes involves an absolute lack of insulin production, blood sugar levels in people with the condition tend to be more variable and require more precise, ongoing management. This is part of why intensive monitoring tools, including continuous glucose monitors and insulin pumps, are frequently prescribed for Type 1 patients and why insurance coverage criteria for these devices often reference insulin use as a qualifying factor.

What Makes Type 2 Diabetes Different

Type 2 diabetes develops differently. Rather than the immune system destroying insulin-producing cells, the body’s cells become resistant to the effects of insulin, and over time the pancreas often can’t produce enough insulin to overcome that resistance. People with Type 2 diabetes typically continue producing at least some of their own insulin, sometimes for decades after diagnosis, though that production tends to decline over time.

Type 2 diabetes is linked to a mix of genetic and lifestyle factors, including body weight, physical activity levels, and diet, though genetics play a meaningful role as well and not everyone who develops Type 2 diabetes has obvious lifestyle risk factors. Risk increases with age, and it’s also more common in people with a family history of diabetes, prior gestational diabetes, polycystic ovary syndrome, high blood pressure, or certain cholesterol patterns, and it occurs more frequently in some racial and ethnic groups.

Symptoms of Type 2 diabetes often develop gradually and can be easy to miss for months or years, which is why routine screening matters even without obvious symptoms. Treatment frequently starts with lifestyle changes and oral medications that improve the body’s insulin sensitivity or reduce glucose production, though many people with Type 2 diabetes eventually need insulin as well, particularly as the condition progresses.

Can Type 2 Diabetes Be Reversed?

Unlike Type 1 diabetes, which currently has no cure and always requires insulin, Type 2 diabetes can sometimes go into remission, meaning blood sugar returns to a normal range without medication. This generally requires significant, sustained changes, often meaningful weight loss achieved through intensive lifestyle intervention or, in some cases, metabolic surgery. Remission isn’t guaranteed and isn’t the same as a cure, since the underlying tendency toward insulin resistance can return, but it is a realistic goal for some patients working closely with their care team.

Why the Distinction Matters for Insurance Coverage

The difference between Type 1 and Type 2 diabetes has real practical consequences for insurance coverage, particularly for CGMs and insulin pumps:

Insulin use as a qualifying factor

Since Type 1 diabetes always involves insulin therapy, Type 1 patients generally meet the insulin-based qualifying criteria that Medicare and most insurers use for CGM coverage. Type 2 patients may or may not use insulin, depending on how advanced their condition is, which means CGM eligibility for Type 2 patients often depends more heavily on the alternative qualifying path: a documented history of problematic hypoglycemia.

State Medicaid variation

Some state Medicaid programs cover CGMs only for Type 1 diabetes, while others extend coverage to Type 2 diabetes as well, particularly for insulin users. This is one of the more significant sources of coverage variation between states, and it’s worth confirming directly for your specific state rather than assuming based on general Medicaid policy.

Insulin pump eligibility

Because insulin pumps are specifically designed for patients on intensive insulin therapy, pump coverage more commonly applies to Type 1 patients, though Type 2 patients using multiple daily insulin injections may also qualify depending on their specific treatment plan and insurer’s criteria.

Getting a Clear Diagnosis

If there’s ever uncertainty about which type of diabetes you have, particularly for adults diagnosed later in life without classic Type 2 risk factors, your doctor may recommend additional testing, such as checking for specific antibodies associated with the autoimmune process behind Type 1 diabetes. Getting this classification right matters, since the recommended treatment approach, insulin requirements, and monitoring intensity differ substantially between the two conditions.

Getting Your Supplies Covered

Whether you have Type 1 or Type 2 diabetes, Diabetic Discounts Network verifies your specific insurance coverage for the CGMs, glucose meters, test strips, and insulin pump supplies your treatment plan requires. Our team confirms which qualifying criteria apply to your specific diagnosis and treatment, so you know clearly what’s covered before anything ships.

Frequently Asked Questions

Type 1 diabetes is an autoimmune condition where the body stops producing insulin entirely, requiring lifelong insulin therapy. Type 2 diabetes involves insulin resistance and often declining insulin production over time, and is treated with a combination of lifestyle changes, oral medications, and sometimes insulin.

Yes. While Type 1 diabetes is often diagnosed in children and young adults, it can develop at any age, and the older idea that it only affects children is outdated.

Not necessarily, but many people with Type 2 diabetes do eventually need insulin as the condition progresses and the pancreas produces less of it over time.

Some people achieve remission, meaning normal blood sugar without medication, typically through significant sustained weight loss via intensive lifestyle changes or metabolic surgery. This isn’t guaranteed for everyone and isn’t considered a permanent cure.

It can. Insulin use is one common qualifying path for CGM coverage, which most Type 1 patients meet by default. Type 2 patients not using insulin may need to qualify through a documented history of problematic hypoglycemia instead, and some state Medicaid programs limit CGM coverage to Type 1 diabetes specifically.

Diagnosis typically considers your age, symptoms, and risk factors, and in ambiguous cases, particularly for adults without classic Type 2 risk factors, additional antibody testing can help confirm or rule out Type 1 diabetes.

This page provides general educational information and is not a substitute for medical advice. Talk to your doctor about your specific diagnosis and treatment plan.